Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical Carcinoma
Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical Carcinoma (ACCOMPLISH)
Evidence level: Klinikai vizsgálat. Formális klinikai vizsgálati eredmény.
Related signals
- Adrenocortical Carcinoma
- Oncological Management of Adrenocortical Carcinoma: An Update and Critical Review
- Targeting pediatric adrenocortical carcinoma: Molecular insights and emerging therapeutic strategies
- Novel Targeted Therapies in Adrenocortical Carcinoma
- Impact of steroid differentiation on tumor microenvironment revealed by single-nucleus atlas of adrenal tumors